Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
A biological specimen is a fragment or portion of a sample that has been chosen for testing. Most clinical laboratories accept serum samples, virology swab samples, biopsy and necropsy tissue, cerebrospinal fluid, whole blood for polymerase chain reaction (PCR), and urine samples as biological samples. These are collected in appropriate containers in order for successful laboratory processing.
Blood and swabs are the most common techniques used to collect both bacterial and viral specimens.
Blood culture test is one of the test used to help find harmful bacteria in the body. The blood tests used for virus infection investigation include complete blood count, C-reactive protein (CRP), serology, and others.
Swabs are collected from the nose, pharynx, tonsil, eye, ear, skin, abscesses, vagina, cervix, and other parts of the body. Using an appropriate transport medium to avoid drying of specimens after collection and throughout shipment is essential.
Global Bacterial & Viral Specimen Collection Market - Impact of the Coronavirus (COVID-19) Pandemic
Coronavirus (COVID-19) outbreak was first reported on December 31, 2019, in Wuhan, China. The World Health Organization declared COVID-19 as pandemic on March 11, 2020. According to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 213 million cases and 4.48 million deaths due to coronavirus disease (COVID-19) were reported till August 25, 2021, across the globe.
Impact of COVID-19 on Demand and Supply of Bacterial & Viral Specimen Collection
The COVID-19 pandemic and lockdown in various countries across the globe have impacted the financial status of businesses across all sectors including private healthcare sector. The COVID-19 pandemic has impacted the entire supply chain of the healthcare industry mainly due to strict lockdown in several regions. The COVID-19 pandemic has affected the economy of various regions across the globe in three main ways; 1) by directly affecting the production and demand; 2) by creating disruptions in distribution channels; and 3) through its financial impact on companies and financial markets. Several countries such as Thailand, Indonesia, and Singapore are facing problems with regards to transportation and distribution of healthcare products.
However, impact of the coronavirus (COVID-19) pandemic is expected to drive the growth of the global bacterial & viral specimen collection market during the forecast period, owing to the approvals of new test kits for COVID-19 sample collection. For instance, on March 13, 2020, Roche, a multinational healthcare company announced that the U.S. Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for the cobas SARSCoV2 test. It is used to qualitatively detect SARSCoV2, the virus that causes COVID-19, in nasopharyngeal and oropharyngeal swab samples from patients that meet COVID-19 clinical and / or epidemiological testing standards.
The global bacterial & viral specimen collection market is estimated to be valued at US$ 17.50 Bn in 2021, and is expected to exhibit a CAGR of 14% over the forecast period (2021-2028).
Figure 1: Global Bacterial & Viral Specimen Collection Market Share (%) Analysis, By Product of Bacterial Specimen Collection, 2021
The increasing cases of tuberculosis which is caused due to bacteria and requires bacterial specimen for diagnosis, is expected to drive growth of the market over the forecast period.
The emerging cases of tuberculosis is expected to bolster the growth of global bacterial & viral specimen collection market. For instance, according to World Health Organization report 2020, in 2019, 1.4 million individuals died from tuberculosis (TB) across the world (including 208,000 HIV-positive people). Furthermore, in 2019, an estimated 10 million people globally contracted tuberculosis (TB) that is 5.6 million men, 3.2 million women, and 1.2 million children.
Bacterial & Viral Specimen Collection Market Report Coverage
||Market Size in 2021:
||US$ 17.50 Bn
|Historical Data for:
||2017 to 2020
||2021 to 2028
|Forecast Period 2021 to 2028 CAGR:
||2028 Value Projection:
||US$ 44.43 Bn
- North America: U.S. and Canada
- Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
- Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
- Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
- Middle East: GCC, Israel, and Rest of Middle East
- Africa: South Africa, North Africa, and Central Africa
- By Product Type: Bacterial Specimen Collection (Swabs, Bacterial Transport Media, Blood Collection Kits, Others), Viral Specimen Collection (Swabs, Viral Transport Media, Blood Collection Kits, Others)
- By Application: Diagnostics, Research
- By End User: Hospitals, Clinics, Diagnostic Laboratories, Research or Academic Organizations, Others
Puritan Medical Products, COPAN Diagnostics, Becton Dickinson and Company, Thermo Fisher Scientific, Inc., Quidel Corporation, Longhorn Vaccines and Diagnostics LLC, Trinity Biotech, HiMedia Laboratories, Hardy Diagnostics, VIRCELL S.L., DiaSorin, and Titan Biotech
- Increasing cases of tuberculosis
- Increasing product launches and approvals
- Increasing government initiatives related to bacterial diseases
|Restraints & Challenges:
- Contamination of blood samples leading to false positive results
Increase in the government initiatives related to bacteria caused diseases is expected to boost the growth of global bacterial & viral specimen collection market. For instance, on April 26, 2019, Kenneth I. Juster, the U.S.' Ambassador to India, announced the initiation of a bold new effort aimed at energizing India's corporate sector in the battle against tuberculosis (TB). The program establishes a unified platform for businesses committed to eradicating tuberculosis in India. The U.S. Agency for International Development (USAID), U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Institutes of Health and the Indian government collaborated for this initiative. This collaboration was done to combat the burden of tuberculosis, particularly multidrug-resistant tuberculosis, by forming public-private partnerships that speed up testing, diagnosis, and research to develop new TB drugs and vaccines.
Global Bacterial & Viral Specimen Collection Market – Restraints
The contamination of blood leading to false positive results of the blood tests restraints growth of the global bacterial & viral specimen collection market. For instance, on August 24, 2020, the test results of National Football League (NFL) players in the U. S. got contaminated during processing at BioReference Laboratories in New Jersey, according to the company. The tests were reexamined and determined to be false positives in eleven clubs. The Minnesota Vikings had 12, the New York Jets had 10, and the Chicago Bears had 9 false positives. The entire episode brought the NFL and its testing procedures through BioReference to an unstable position.
Global Bacterial & Viral Specimen Collection Market – Regional Analysis
On the basis of region, the global bacterial & viral specimen collection market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
North America is expected to hold dominant position in the global bacterial & viral specimen collection market over the forecast period, owing to the new product launches and approvals. For instance, on November 06, 2020, GenScript USA Inc., a global biotechnology company, announced that the U.S. Food and Drugs Administration (FDA) issued an emergency use authorization (EUA) for the company's cPass SARSCoV2 Neutralizing Antibody Detection Kit. It is the first serological test approved which can detect neutralizing antibodies from recent or prior SARSCoV2 infection.
Moreover, due to product launches or approvals, Europe is expected to witness a significant growth in global bacterial & viral specimen collection market over the forecast period. For instance, on February 1, 2021, Roche announced that its new SARSCoV2 rapid antigen test nose has received the CE (Conformité Européenne) mark. Compared to the existing Roche SARSCoV2 Rapid Antigen Test, the SARSCoV2 Rapid Antigen Nasal Test collects swabs from the front area of ??the nose rather than the nasopharynx, simplifying and speeding up the testing procedure.
Figure 2: Global Bacterial & Viral Specimen Collection Market Value (US$ Bn), by Region, 2021
Global Bacterial & Viral Specimen Collection Market – Competitive Landscape
Major players operating in the global bacterial & viral specimen collection market include Puritan Medical Products, COPAN Diagnostics, Becton Dickinson and Company, Thermo Fisher Scientific, Inc., Quidel Corporation, Longhorn Vaccines and Diagnostics, LLC, Trinity Biotech, HiMedia Laboratories, Hardy Diagnostics, VIRCELL S.L., DiaSorin, and Titan Biotech.